[HTML][HTML] Clinical strategies in the testing of thyroid function

U Feldt-Rasmussen, M Klose - Endotext [Internet], 2020 - ncbi.nlm.nih.gov
In the past decades, emphasis has shifted from testing thyroid function in individuals who
are likely to have clinically overt thyroid disorders to a broader population, an approach that …

Basal or stimulated thyroglobulin in evaluating response to treatment in papillary thyroid carcinoma? A retrospective cohort study

L Barreto, DCG Ferreira, JE Corrente, CSP Soares… - Hormones, 2024 - Springer
Objective It is not clear whether response to initial treatment in papillary thyroid carcinoma
(PTC) patients is best evaluated by measuring thyroglobulin (Tg) in the presence of …

[HTML][HTML] Examination of malignant findings of thyroid nodules using thyroid ultrasonography

D Saito, R Nakajima, S Yasuda - Journal of Clinical Medicine …, 2020 - ncbi.nlm.nih.gov
Background It is important to distinguish benign thyroid nodules from malignant thyroid
nodules. Hence, this study aimed to determine the characteristics of patients with thyroid …

Comparison of Prognostic Value Between Stimulated and Nonstimulated Thyroglobulins in Differentiated Thyroid Cancer: A Retrospective Study

J Son, CM Hong, DH Kim, SY Jeong, SW Lee… - Nuclear Medicine and …, 2023 - Springer
Purpose The growing incidence of differentiated thyroid cancer (DTC) demands dependable
prognostic factors to guide follow-up and treatment plans. This study investigated the …

Undetectable thyroglobulin makes 123I whole-body scan and stimulated thyroglobulin obsolete in follow-up care of differentiated thyroid cancer: a retrospective study

B Sol, B Bravenboer, B Velkeniers, S Raeymaeckers… - Thyroid research, 2021 - Springer
Background Differentiated thyroid cancer (DTC) is a common malignancy with increasing
incidence. Follow-up care for DTC includes thyroglobulin (Tg) measurement and ultrasound …

Radiation exposure to allied health personnel handling blood specimens from patients receiving radioactive iodine-131 and recombinant human TSH (Thyrogen®) …

TB Sarah, Y Peiling, TP Loo, WY Ming… - Journal of …, 2021 - iopscience.iop.org
With increasing use of recombinant human TSH (rhTSH) stimulation protocol in radioactive
iodine-131 treatment of thyroidectomised differentiated thyroid carcinoma (DTC), there is …

Case report of delayed metastasis from thyroid micropapillary carcinoma to the deltoid muscle in a patient with thyroglobulin elevated negative iodine scintigraphy …

R Ramachandran, AV Pillai… - Formosan Journal of …, 2022 - journals.lww.com
Differentiated thyroid cancers are common but distant metastasis to the muscles is rare. We
present a case of 64-year-old male who underwent thyroidectomy for a suspicious thyroid …

Use of Recombinant TSH in the Treatment and Monitoring of Well-Differentiated Thyroid Cancers

E Özkan, M Araz - Nukleer Tıp Seminerleri, 2021 - search.proquest.com
Differentiated thyroid cancer (DTC) is an endocrine tumour with mostly good prognosis that
requires life long followup. Primary treatments are total thyroidectomy (TT) and radioactive …

Iyi Diferansiye Tiroid Kanserlerinin Tedavi ve Izleminde Rekombinant TSH Kullanimi/Use of Recombinant TSH in the Treatment and Monitoring of Well-Differentiated …

E Özkan, M Araz - Nuclear Medicine Seminars, 2021 - go.gale.com
Diferansiye tiroid kanseri (DTK) ömür boyu takip gerektiren çogunlukla iyi prognozlu bir
endokrin tümördür. Primer tedavisi total tiroidektomi (TT) ve radyoaktif iyot (RAI) tedavisidir …

Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?

E Jeong, JK Yoon, SJ Lee, EY Soh, J Lee, HK Kim… - Medicine, 2019 - journals.lww.com
This study investigated the correlation between basal thyroglobulin (Tg) and recombinant
human thyroid-stimulating hormone (rhTSH)-stimulated Tg in differentiated patients with …